Amyris Inc (AMRS) Stock
AMRS is no longer traded. Amyris was delisted from the Nasdaq in August 2023.
Prices on this page are historical; the last trade was August 18, 2023 at $0.05.
Amyris stock price history
AMRS final trading statistics
- Final close
- $0.05
- Final trading day
- Aug 18, 2023
- Market cap at delisting
- $18.47M
- Shares outstanding
- 369.39M
- Final 52-week range
- $0.05 – $4.86
- Avg. volume (final 3 mo.)
- 23,870,740
- All-time high (split-adj.)
- $1280.25 · Dec 2013
- All-time low (split-adj.)
- $0.05 · Aug 2023
- Return since IPO
- -100.0%
- Beta
- 1.19
- Book value / share
- -$1.80
- Price / book
- -0.03
Amyris annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $269.85M | -$535.9M | -$1.68 |
| FY2021 | $341.82M | -$264.2M | -$0.98 |
| FY2020 | $173.14M | -$324.1M | -$1.79 |
| FY2019 | $80.42M | -$211.3M | -$1.88 |
| FY2018 | $63.60M | -$230.2M | -$3.56 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Amyris Inc
Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Amyris stock FAQ
What happened to Amyris stock?
Amyris stock was delisted from the Nasdaq. Its final close was $0.05 on August 18, 2023.
Is AMRS stock still trading?
No. AMRS was delisted from the Nasdaq in August 2023 and no longer trades on a U.S. exchange.
What was the last price of AMRS stock?
AMRS closed at $0.05 on its final trading day, August 18, 2023, for a market value of about $18.47M.
What were Amyris's revenue and earnings in its last full fiscal year?
Amyris reported revenue of $269.85M and net income of -$535.9M in fiscal 2022, its last full year as a public company.
When did Amyris go public?
Amyris Inc stock began trading on September 28, 2010.